PMQs - live: Starmer to face Sunak grilling as Labour MP insists assisted dying won’t put vulnerable at risk
Labour government will allow free vote by MPs on controversial assisted dying bill
Your support helps us to tell the story
This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
Sir Keir Starmer is set to face off against Rishi Sunak at Prime Minister’s Questions (PMQs) shortly before a private members bill on assisted dying is due to be formally introduced to the House of Commons.
Labour MP Kim Leadbeater, who is bringing forward the proposals, has said that disabled and vulnerable people will not be at risk from the legislation as it will apply only to terminally ill adults.
She said the end of life bill will have “stringent” criteria and the legislation was about giving “autonomy” to people at the end of their lives.
She told ITV’s Good Morning Britain: “The health inequalities in this country, the pressure that disabled people feel and the fact that they don’t feel they’ve got the same rights as other people, let’s address those issues, and I will champion those causes all day long.
“But this is about people who are terminally ill, who just want the autonomy to have the choice to end their lives in a way that they feel more comfortable with, that respects their family and their friends and their loved ones.”
Unemployed to be given weight-loss jab to help them back into work
Unemployed people will be given weight-loss jabs to assist them back into work in a trial.
The UK’s life sciences sector will receive £279 million from drugs giant Eli Lilly, to invest in developing new medicines and ways to deliver treatment.
Amanda Pritchard, Chief Executive of the NHS praised weight-loss drugs as “game-changers” in supporting people to reduce their risk of life-threatening conditions.
Jabed Ahmed reports
Unemployed to be given weight-loss jab to help them back into work, government says
The new trial aims to gather evidence of the effects of the drug tirzepatide – sold by pharmaceutical company Lily under brand name Mounjaro
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments